Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2]

She has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare. Before being appointed as GSK’s CEO, Emma was the CEO of GSK Consumer Healthcare, a joint venture between …

(Courtesy GSK) GlaxoSmithKline appointed Emma Walmsley, the head of its consumer business, to become its next chief executive. She is the first woman to run a major pharmaceutical giant. Walmsley...

May 21, 2024 · When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.

Apr 11, 2025 · In her eight-year tenure as chief executive officer of GSK Plc, Emma Walmsley has seen off a combative activist investor, navigated multi-billion dollar litigation in the US and spun out a ...

Feb 28, 2025 · For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation...

Jan 23, 2021 · Emma Walmsley succeeded Sir Andrew Witty who was leading GSK for almost a decade. Her mission was to make GSK innovative, customer focused and successful again.

Jun 21, 2023 · Dame Emma Walmsley is the first female CEO at the British pharmaceutical company GSK plc from 2017. She replaced Andrew Witty. GSK CEO Emma Walmsley’s appointment fueled the speculation that the company would prioritize its consumer operation. However, she stressed that producing and commercializing new medicines will be the focus.

May 31, 2023 · On this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram talk with GSK CEO Emma Walmsley about the future of A.I. in the pharmaceutical industry, the...

Apr 21, 2023 · Headlining exciting innovation in the pharmaceutical world, Dame Emma Walmsley has been the CEO of GSK since 2017, making her the first woman to run a major pharmaceutical company.